AVROBIO
+$0.81 (+9.22%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell AVROBIO and other stocks, options, and ETFs commission-free!
About AVRO
Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen.
CEO
Geoff MacKay
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
2015
AVRO Key Statistics
Market Cap
386.81M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
673.15K
High Today
$9.79
Low Today
$8.73
Open Price
$8.75
Volume
510.20K
52 Week High
$23.50
52 Week Low
$7.45
Analyst Ratings
75%
of 8 ratings
Buy
75%
Hold
25%
Sell
0%
AVRO Earnings
-$1.01
-$0.67
-$0.34
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.77 per share
Actual
-$0.65 per share